Patients With Severe Gastrointestinal Dysmotility Disorders Receiving Home Parenteral Nutrition Have Similar Survival As Those With Short-Bowel Syndrome: A Prospective Cohort Study.
Ennaliza SalazarNayima M Clermont-DejeanKatherine J P SchwengerJessica NoeltingZihang LuWendy LouJohane P AllardPublished in: JPEN. Journal of parenteral and enteral nutrition (2020)
T5- and 10- year survival probabilities were similar between GID and SBS patients. The diagnosis of scleroderma had no effect on survival. Use of immunosuppressant, older age, PN dependence, and number of hospitalizations per PN duration are risk factors for mortality in both the GID and SBS groups.